Entering an Era of More Personalized Treatment in Lung Cancer:
Increasing Patient Survival Rates
Presented by the Johns Hopkins University School of Medicine
4.0 AMA PRA Category 1 Credits™ available
VIDEO PRESENTATIONS
Are We Ready to Move to Annual Screening for Lung Cancer in High Risk Patients?
• Claudia I. Henschke, MD, Mount Sinai Medical Center
Recent Developments in Targeted Therapy for NSCLC
• David Jackman, MD, Harvard Medical School
Application of Advancements in Biomarker Identification to Clinical Practice in Patients with NSCLC. Is it Ready for Primetime?
• Peter Bela Illei, MD, Johns Hopkins Medicine Bayview Medical Center
Optimizing Therapy Choices in Patients with SCLC
• Jeffrey Crawford, Duke University Medical Center
Registration
* indicates a required field

